Feature

Research Innovations from ROI

The Radiation Oncology Institute (ROI) ‒ the ASTRO Foundation ‒ accelerates research and education to advance patient care in radiation oncology. Since 2006, ROI has funded high-impact projects that improve quality, safety, health equity, and innovation across the field. Attend an ROI-funded research presentation at the ASTRO Annual Meeting or learn more at ROInstitute.org.

“How to acquire targeted on-treatment research biopsies in patients receiving GRID is just one of the many challenges we have overcome in this trial and we are thrilled to report our initial experience, including results from our first safety analysis – hoping to connect with the GRID community in San Francisco!”

Ted K. Yanagihara, MD, PhD (right) and Leith Rankine, PhD (left)

Sunday, September 28

PQA 01 | 2:30 p.m. - 4:00 p.m.

PI & Presenter: Ted K. Yanagihara, MD, PhD
Spatially Fractionated Radiotherapy Followed by Pre-Operative Radiotherapy for Resectable Soft Tissue Sarcoma: Interim Safety Results of a Prospective Trial

PI & Presenter: Baozhou Sun, PhD, MBA
Dosimetric Impact of CT Simulation vs. Diagnostic CT in Palliative Radiation Therapy Planning in a Low-Resource Clinic: A DVH Analysis

PI: Baozhou Sun, PhD, MBA | Presenter: Yiding Han, PhD
AI-Based Synthetic Simulation CT Generation from Diagnostic CT for Simulation-Free Radiotherapy Workflow in a Low Resource Setting

SS 10 | 4:45 p.m. - 6:00 p.m.

PI & Presenter: Ryan T. Hughes, MD
Feasibility and Acceptability of Carotid Ultrasound to Identify Head and Neck Cancer Survivors with High Cardiovascular Risk after Radiation Therapy: Results of a Prospective Study

PQA 02 | 4:45 p.m. - 6:00 p.m.

PI: Julian C. Hong, MD, MS | Presenter: Michelle Zhao, BA
Site-Specific Associations between NCCN Distress Thermometer Screening Data and NLP-Identified Toxicities During Radiotherapy

PI & Presenter: Ryan T. Hughes, MD
High-risk Carotid Artery Ultrasound Findings in Head and Neck Cancer Survivors after Radiation Therapy: Results of a Prospective Study

“Come see how we’re working to change the face of cancer care in Alaska by empowering Alaska Native students through mentorship and early exposure to radiation oncology to tackle deep-rooted health care disparities.”

Laura Aspelund, BS (WWAMI Med Student and ANION mentor), presenting with Joceyln Waggoner

Monday, September 29

SS 30 | 5:00 p.m. - 6:00 p.m.

PI: Ted K. Yanagihara, MD, PhD | Presenter: Leith Rankine, PhD
Design and Implementation of Combined Spatially Fractionated Radiotherapy and Image-Guided On-Treatment Biopsy for Resectable Soft Tissue Sarcoma Patients Enrolled in Prospective Clinical Trial LCCC2250

PQA 06 | 5:00 p.m. - 6:00 p.m.

PI: Dan Seible, MD | Presenters: Laura E. Aspelund, BS & J. Waggoner
Alaska Native Internship in ONcology (ANION): A Novel Pilot Program Addressing Oncology Workforce Deficits in Alaskan Healthcare through Mentorship in Radiation Therapy

Tuesday, September 30

SS 34 | 8:00 a.m. - 9:00 a.m.

PI: Joseph Harms, PhD | Presenter: Roman Vasyltsiv, BS
Recovering Dose Dynamics and Dose Rate Volume Histograms in UHDR PBS Proton Therapy Using Scintillation Array Dosimetry

PQA 07 | 12:45 p.m. - 2:00 p.m.

PI: Julian C. Hong, MD, MS | Benjamin Hyams, BA
Large Language Models Applied to Patient Messages for Predicting Acute Care Risk during Radiation Therapy